Literature DB >> 8153632

Association of intestinal peptide transport with a protein related to the cadherin superfamily.

A H Dantzig1, J A Hoskins, L B Tabas, S Bright, R L Shepard, I L Jenkins, D C Duckworth, J R Sportsman, D Mackensen, P R Rosteck.   

Abstract

The first step in oral absorption of many medically important peptide-based drugs is mediated by an intestinal proton-dependent peptide transporter. This transporter facilitates the oral absorption of beta-lactam antibiotics and angiotensin-converting enzyme inhibitors from the intestine into enterocytes lining the luminal wall. A monoclonal antibody that blocked uptake of cephalexin was used to identify and clone a gene that encodes an approximately 92-kilodalton membrane protein that was associated with the acquisition of peptide transport activity by transport-deficient cells. The amino acid sequence deduced from the complementary DNA sequence of the cloned gene indicated that this transport-associated protein shares several conserved structural elements with the cadherin superfamily of calcium-dependent, cell-cell adhesion proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8153632     DOI: 10.1126/science.8153632

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  40 in total

Review 1.  Intestinal peptide transport systems and oral drug availability.

Authors:  C Y Yang; A H Dantzig; C Pidgeon
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

2.  Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs.

Authors:  Duxin Sun; Hans Lennernas; Lynda S Welage; Jeffery L Barnett; Christopher P Landowski; David Foster; David Fleisher; Kyung-Dall Lee; Gordon L Amidon
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

3.  Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter.

Authors:  Kazutoshi Horie; Fuxing Tang; Ronald T Borchardt
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

4.  Altered expression of a Li-cadherin in gastric cancer and intestinal metaplasia.

Authors:  Weiguo Dong; Qiongfang Yu; Yu Xu
Journal:  Dig Dis Sci       Date:  2007-01-17       Impact factor: 3.199

5.  In vitro permeability through caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transporter system.

Authors:  S Chong; S A Dando; K M Soucek; R A Morrison
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

6.  Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer.

Authors:  Reiko Ito; Naohide Oue; Kazuhiro Yoshida; Kyoko Kunimitsu; Hirofumi Nakayama; Kei Nakachi; Wataru Yasui
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

7.  hPepT1-mediated epithelial transport of bacteria-derived chemotactic peptides enhances neutrophil-epithelial interactions.

Authors:  D Merlin; A Steel; A T Gewirtz; M Si-Tahar; M A Hediger; J L Madara
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

8.  A modified coumarinic acid-based cyclic prodrug of an opioid peptide: its enzymatic and chemical stability and cell permeation characteristics.

Authors:  Hui Ouyang; Fuxing Tang; Teruna J Siahaan; Ronald T Borchardt
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

9.  Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?

Authors:  Fuxing Tang; Kazutoshi Horie; Ronald T Borchardt
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

10.  Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.

Authors:  Fuxing Tang; Ronald T Borchardt
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.